Acute exercise elicits differential expression of insulin resistance genes in the skeletal muscle of patients with polycystic ovary syndrome
Carregando...
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
DANTAS, Wagner Silva
MURAI, Igor Hisashi
PERANDINI, Luiz Augusto
CAMARA, Niels Olsen Saraiva
Citação
CLINICAL ENDOCRINOLOGY, v.86, n.5, p.688-697, 2017
Resumo
ObjectiveThis study aimed to explore the role of acute exercise on skeletal muscle gene expression related to insulin resistance in patients with polycystic ovary syndrome (PCOS) and controls. MethodsFour obese women with PCOS and four body mass index (BMI)-matched controls (CTRL) participated in this study. After an overnight fast, the subjects underwent a single 40-min bout of aerobic exercise. Muscle samples were obtained from vastus lateralis at baseline and 60 min after exercise. The expression of a panel of insulin resistance genes was evaluated by a quantitative PCR array system. Network-based analyses were performed to interpret transcriptional changes occurring before and after the exercise challenge. ResultsOverall, differentially expressed genes associated with mitochondria function and peroxisome proliferator-activated receptor signalling were identified. At baseline, there was a significant upregulation of six genes exclusively in PCOS (i.e. NFKBIA, MAPK3, PPARGC1A, GAPDH, ACTB and PPARA). Twelve genes were upregulated in CTRL after a single bout of aerobic exercise (i.e. LEPR, CXCR4, CCR5, IL-18R1, CRLF2, ACACA, CEBPA, PPARGC1A, UCP1, TNFRSF1B, TLR4 and IKBKB). After the exercise session, three genes were upregulated in PCOS (i.e. SOCS3, NAMPT and IL-8), whilst IL-6 was upregulated in both groups after exercise. ConclusionsThis study provides novel evidence on the effects of acute exercise on insulin resistance genes in skeletal muscle of PCOS. The differentially expressed genes reported herein could be further investigated as targets for therapeutic interventions aimed at improving insulin resistance in this syndrome.
Palavras-chave
Referências
- Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519
- Adjeitey CNK, 2013, AM J PHYSIOL-ENDOC M, V305, pE405, DOI 10.1152/ajpendo.00057.2013
- Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735
- Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046
- Chazenbalk G, 2012, J CLIN ENDOCR METAB, V97, pE765, DOI 10.1210/jc.2011-2377
- Corbould A, 2006, DIABETES, V55, P751, DOI 10.2337/diabetes.55.03.06.db05-0453
- Costford SR, 2010, AM J PHYSIOL-ENDOC M, V298, pE117, DOI 10.1152/ajpendo.00318.2009
- Covington JD, 2016, BIOCHIMIE, V124, P27, DOI 10.1016/j.biochi.2014.10.028
- Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325
- Dantas WS, 2015, OBESITY, V23, P2207, DOI 10.1002/oby.21217
- Fields DA, 2000, INT J OBESITY, V24, P200, DOI 10.1038/sj.ijo.0801113
- Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021
- Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z
- Frosig C, 2007, DIABETES, V56, P2093, DOI 10.2337/db06-1698
- Frydelund-Larsen L, 2007, EXP PHYSIOL, V92, P233, DOI 10.1113/expphysiol.2006.034769
- Gonzalez F, 2012, J CLIN ENDOCR METAB, V97, P2836, DOI 10.1210/jc.2012-1259
- Harrison CL, 2012, CLIN ENDOCRINOL, V76, P351, DOI 10.1111/j.1365-2265.2011.04160.x
- Hojlund K, 2008, DIABETES, V57, P357, DOI 10.2337/db07-0706
- Huffman KM, 2014, DIABETOLOGIA, V57, P2282, DOI 10.1007/s00125-014-3343-4
- Hutchison SK, 2012, DIABETOLOGIA, V55, P1424, DOI 10.1007/s00125-011-2442-8
- Kraniou Y, 2000, J APPL PHYSIOL, V88, P794
- Lansley KE, 2011, INT J SPORTS MED, V32, P535, DOI 10.1055/s-0031-1273754
- Levy YA, 2015, AM J PHYSIOL-ENDOC M, V309, pE22, DOI 10.1152/ajpendo.00513.2014
- Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562
- Morton TL, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00080
- Neubauer O, 2014, J APPL PHYSIOL, V116, P274, DOI 10.1152/japplphysiol.00909.2013
- Pilegaard H, 2000, AM J PHYSIOL-ENDOC M, V279, pE806
- Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3
- Popov DV, 2015, J MOL ENDOCRINOL, V55, P159, DOI 10.1530/JME-15-0150
- Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161
- Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76
- Schnyder S, 2015, BONE, V80, P115, DOI 10.1016/j.bone.2015.02.008
- Skov V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002466
- Skov V, 2007, DIABETES, V56, P2349, DOI 10.2337/db07-0275
- Stener-Victorin E, 2012, FERTIL STERIL, V97, P501, DOI 10.1016/j.fertnstert.2011.11.010
- Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596
- Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576
- Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666
- WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236
- Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724